{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T05:16:40Z","timestamp":1789881400056,"version":"4.0.1"},"reference-count":32,"publisher":"American Psychiatric Association Publishing","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[2006,1,1]]},"DOI":"10.1176\/appi.ajp.163.1.59","type":"journal-article","created":{"date-parts":[[2006,1,3]],"date-time":"2006-01-03T17:03:00Z","timestamp":1136307780000},"page":"59-66","source":"Crossref","is-referenced-by-count":87,"title":["Placebo-Controlled Trial of Dehydroepiandrosterone (DHEA) for Treatment of Nonmajor Depression in Patients With HIV\/AIDS"],"prefix":"10.1176","volume":"163","author":[{"given":"Judith G.","family":"Rabkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C.","family":"McElhiney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Rabkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Ferrando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R1631CACGIAAG","doi-asserted-by":"crossref","unstructured":"Ferrando SJ, Wapenyi K: Psychopharmacological treatment of patients with HIV and AIDS. Psychiatr Q 2002; 73:33\u201349","DOI":"10.1023\/A:1012840717735"},{"key":"R1631CACEEIJH","doi-asserted-by":"crossref","unstructured":"Griffin K, Rabkin JG: Psychological distress in people with HIV\/AIDS: prevalence rates and methodological issues. AIDS Behav 1997; 1:29\u201342","DOI":"10.1023\/A:1026261820964"},{"key":"R1631CACGGHDG","doi-asserted-by":"crossref","unstructured":"Rabkin JG, Wagner GJ, Rabkin R: A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms. Arch Gen Psychiatry 2000; 57:141\u2013147","DOI":"10.1001\/archpsyc.57.2.141"},{"key":"R1631CACEEHGG","unstructured":"Tomera JF: Dehydroepiandrosterone and aging. Drugs Today 1996; 32:453\u2013461"},{"key":"R1631CACFCHEH","doi-asserted-by":"crossref","unstructured":"Johnson M, Bebb R, Sirrs S: Uses of DHEA in aging and other disease states. Ageing Res Rev 2002; 1:29\u201341","DOI":"10.1016\/S0047-6374(01)00369-4"},{"key":"R1631CACDGCCD","doi-asserted-by":"crossref","unstructured":"Brebner K, Hayley S, Zacharko R, Merali Z, Anisman H: Synergistic effects of interleukin-1beta, interleukin-6 and tumor necrosis factor-alpha: central monoamine, corticosterone, and behavioral variations. Neuropsychopharmacology 2000; 22:566\u2013580","DOI":"10.1016\/S0893-133X(99)00166-9"},{"key":"R1631CACJIAFF","doi-asserted-by":"crossref","unstructured":"Soares CD, Musolino N, Cunha A, Neto M, Caires M, Rosenthal M, Camargo C, Bronstein M: Impact of recombinant human growth hormone treatment on psychiatric, neuropsychological and clinical profiles of GH deficient adults: a placebo-controlled trial. Arq Neuropsiquiatr 1999; 57:182\u2013189","DOI":"10.1590\/S0004-282X1999000200003"},{"key":"R1631CACCEHGD","doi-asserted-by":"crossref","unstructured":"Lanquillon S, Drieg J-C, Bening-Abu-Shach U, Vedder H: Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 2000; 22:370\u2013379","DOI":"10.1016\/S0893-133X(99)00134-7"},{"key":"R1631CACJJIJA","doi-asserted-by":"crossref","unstructured":"Wolkowitz OM, Kramer J, Reus V, Costa M, Yaffe K, Walton P, Raskind M, Peskind E, Newhouse P, Sack D, DeSouza E, Sadowsky C, Roberts E: DHEA treatment of Alzheimer\u2019s disease: a randomized double-blind, placebo-controlled study. Neurology 2003; 60:1071\u20131076","DOI":"10.1212\/01.WNL.0000052994.54660.58"},{"key":"R1631CACJEGJA","doi-asserted-by":"crossref","unstructured":"Hunt PJ, Gurnell EM, Huppert FA, Richards C, Prevost AT, Wass JA, Herbert J, Chatterjee VK: Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison\u2019s disease in a randomized, double blind trial. J Clin Endocrinol Metab 2000; 85:4650\u20134656","DOI":"10.1210\/jcem.85.12.7022"},{"key":"R1631CACJDFEI","doi-asserted-by":"crossref","unstructured":"Strous RD, Maayan R, Lapidus R, Stryjer R, Lustig M, Kotler M, Weizman A: Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia. Arch Gen Psychiatry 2003; 60:133\u2013141","DOI":"10.1001\/archpsyc.60.2.133"},{"key":"R1631CACHFHIJ","doi-asserted-by":"crossref","unstructured":"Laudat A, Blum L, Guechot J, Picard O, Cabane J, Imbert J, Giboudeau J: Changes in systemic gonadal and adrenal steroids in asymptomatic HIV-infected men: relationship with the CD4 cell counts. Eur J Endocrinol 1995; 133:418\u2013424","DOI":"10.1530\/eje.0.1330418"},{"key":"R1631CACIDJDB","doi-asserted-by":"crossref","unstructured":"Ferrando SJ, Rabkin J, Poretsky L: Dehydroepiandrosterone (DHEA) and testosterone: relationship to HIV illness stage and progression over one year. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 22:146\u2013154","DOI":"10.1097\/00042560-199910010-00006"},{"key":"R1631CACBFGBG","doi-asserted-by":"crossref","unstructured":"Christeff N, Melchior J-C, de Truchis P, Perronne C, Nunez E, Gougeon ML: Lipodystrophy defined by a clinical score in HIV-infected men on highly active antiretroviral therapy: correlation between dyslipidaemia and steroid hormone alterations. AIDS 1999; 13:2251\u20132260","DOI":"10.1097\/00002030-199911120-00007"},{"key":"R1631CACDBIGC","doi-asserted-by":"crossref","unstructured":"Christeff N, de Truchis P, Melchior J-C, Perronne C, Gougeon ML: Longitudinal evolution of HIV-1-associated lipodystrophy is correlated to serum cortisol: DHEA ratio and IFN-alpha. Eur J Clin Invest 2002; 32:775\u2013784","DOI":"10.1046\/j.1365-2362.2002.01068.x"},{"key":"R1631CACIHFEF","doi-asserted-by":"crossref","unstructured":"Wolkowitz OM, Reus VI, Keebler A, Nelson N, Friedland M, Brizendine L, Roberts E: Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry 1999; 156:646\u2013649","DOI":"10.1176\/ajp.156.4.646"},{"key":"atypb1","doi-asserted-by":"crossref","unstructured":"Bloch M, Schmidt P, Danaceau M, Adams L, Rubinow D: Dehydroepiandrosterone treatment of midlife dysthymia. Biol Psychiatry 1999; 45:1533\u20131541","DOI":"10.1016\/S0006-3223(99)00066-9"},{"key":"R1631CACGGAEE","doi-asserted-by":"crossref","unstructured":"Rabkin JG, Ferrando SJ, Wagner GJ, Rabkin R: DHEA treatment for HIV+ patients: effects on mood, androgenic and anabolic parameters. Psychoneuroendocrinology 2000; 25:53\u201368","DOI":"10.1016\/S0306-4530(99)00036-0"},{"key":"R1631CACEECCI","doi-asserted-by":"crossref","unstructured":"Rabkin JG, Ferrando SJ: DHEA and HIV illness. AIDS Read 1997; 7(1):28\u201336","DOI":"10.3109\/10550499809034712"},{"key":"R1631CACGHGIE","doi-asserted-by":"crossref","unstructured":"Parasrampuria J, Schwartz K: Quality control of dehydroepiandrosterone dietary supplement products (letter). JAMA 1998; 280:1565","DOI":"10.1001\/jama.280.18.1565"},{"key":"R1631CACFCCBC","doi-asserted-by":"crossref","unstructured":"Williams JB: A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry 1988; 45:742\u2013747","DOI":"10.1001\/archpsyc.1988.01800320058007"},{"key":"R1631CACDBCJG","doi-asserted-by":"crossref","unstructured":"Endicott J, Nee J, Harrison W, Blumenthal R: Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull 1993; 29:321\u2013326","DOI":"10.1037\/t49981-000"},{"key":"R1631CACJHIAJ","doi-asserted-by":"crossref","unstructured":"Rabkin JG, Markowitz J, Ocepek-Welikson K: General vs systematic inquiry about emergent clinical events with SAFTEE: implications for clinical research. J Clin Psychopharmacol 1992; 12:3\u201310","DOI":"10.1097\/00004714-199202000-00002"},{"key":"R1631CACHIDHJ","doi-asserted-by":"crossref","unstructured":"Bagatell C, Bremner W: Androgens in men: uses and abuses. N Engl J Med 1996; 334:707\u2013714","DOI":"10.1056\/NEJM199603143341107"},{"key":"R1631CACECJHH","doi-asserted-by":"crossref","unstructured":"McQuay HJ, Moore RA: Using numerical results from systematic reviews in clinical practice. Ann Intern Med 1997; 126:712\u2013720","DOI":"10.7326\/0003-4819-126-9-199705010-00007"},{"key":"R1631CACHBCIH","doi-asserted-by":"crossref","unstructured":"Anderson IM, Tomenson BM: Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. BMJ 1995; 310:1433\u20131438","DOI":"10.1136\/bmj.310.6992.1433"},{"key":"R1631CACIGFCA","doi-asserted-by":"crossref","unstructured":"Rabkin JG, McElhiney M, Ferrando S, van Gorp W, Lin SH: Predictors of employment of men with HIV\/AIDS: a longitudinal study. Psychosom Med 2004; 66:72\u201378","DOI":"10.1097\/01.PSY.0000108083.43147.6D"},{"key":"R1631CACEEBGA","doi-asserted-by":"crossref","unstructured":"Judd L, Akiskal H, Paulus M: The role and clinical significance of subsyndromal depressive symptoms (SSD) in unipolar major depression. J Affect Disord 1997; 45:5\u201318","DOI":"10.1016\/S0165-0327(97)00055-4"},{"key":"R1631CACHEAIH","doi-asserted-by":"crossref","unstructured":"Rapaport MH, Judd LL, Schettler PJ, Yonkers KA, Thase ME, Kupfer DJ, Frank E, Plewes JM, Tollefson GD, Rush AJ: A descriptive analysis of minor depression. Am J Psychiatry 2002; 159:637\u2013643","DOI":"10.1176\/appi.ajp.159.4.637"},{"key":"R1631CACEFFFB","unstructured":"Venning G: Antidepressant drugs have previously been shown ineffective in mild depression (letter). BMJ 2000; 3209:311"},{"key":"R1631CACBABIH","doi-asserted-by":"crossref","unstructured":"Stewart J, McGrath P, Quitkin F, Rabkin J, Harrison W, Wager S, Nunes E, Ocepek-Welikson K, Tricamo E: Chronic depression: response to placebo, imipramine and phenelzine. J Clin Psychopharmacol 1993; 13:391\u2013396","DOI":"10.1097\/00004714-199312000-00004"},{"key":"R1631CACIJCHJ","doi-asserted-by":"crossref","unstructured":"Thase M, Fava M, Halbreich U, Kocsis J, Koran L, Davidson J, Rosenbaum J, Harrison W: A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Arch Gen Psychiatry 1996; 53:777\u2013784","DOI":"10.1001\/archpsyc.1996.01830090023004"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.163.1.59","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T16:09:39Z","timestamp":1721837379000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.163.1.59"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1,1]]}},"alternative-id":["10.1176\/appi.ajp.163.1.59"],"URL":"https:\/\/doi.org\/10.1176\/appi.ajp.163.1.59","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1,1]]}}}